Source: DGNews  |  Posted 8 years ago

By Maury M. Breecher, PhD, MPH

SAN DIEGO, CA -- June 5, 2003 -- The peaks and valleys of active drug associated with oral administration of methylphenidate (MPH) in patients with attention deficit hyperactivity disorder (ADHD) can be avoided by proper use of a once-daily MPH transdermal patch, according to a study presented here May 31st at the American Society of Health-System Pharmacists (ASHP) annual summer meeting.

"A once daily methylphenidate transdermal system (MTS) has been developed that provides consistent and continuous delivery of d-MPH, the active enantiomer of MPH. Varying patch size and wear time permits dose titration," said senior author Mario A. Gonz